Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 9.12.2019 | EN | Official Journal of the European Union | C 413/60 |

---

Action brought on 14 October 2019 – Teva Pharmaceutical Industries v EUIPO (Moins de migraine pour vivre mieux)

(Case T-696/19)

(2019/C 413/72)

Language of the case: English

Parties

Applicant: Teva Pharmaceutical Industries Ltd (Jerusalem, Israel) (represented by: J. Bogatz and Y. Stone, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Details of the proceedings before EUIPO

Trade mark at issue: Application for European Union word mark Moins de migraine pour vivre mieux – Application for registration No 17 942 393

Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 12 August 2019 in Case R 778/2019-5

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | order EUIPO to pay the costs incurred by the applicant. |

Plea in law

Infringement of Article 7(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.

---

[Top](#document1)